Abstract
The metabolic charts memorized in early biochemistry courses, and then later forgotten, have come back to haunt many immunologists with new recognition of the importance of these pathways. Metabolites and the activity of metabolic pathways drive energy production, macromolecule synthesis, intracellular signalling, post-translational modifications and cell survival. Immunologists who identify a metabolic phenotype in their system are often left wondering where to begin and what does it mean? Here, we provide a framework for navigating and selecting the appropriate biochemical techniques to explore immunometabolism. We offer recommendations for initial approaches to develop and test metabolic hypotheses and how to avoid common mistakes. We then discuss how to take things to the next level with metabolomic approaches, such as isotope tracing and genetic approaches. By proposing strategies and evaluating the strengths and weaknesses of different methodologies, we aim to provide insight, note important considerations and discuss ways to avoid common misconceptions. Furthermore, we highlight recent studies demonstrating the power of these metabolic approaches to uncover the role of metabolism in immunology. By following the framework in this Review, neophytes and seasoned investigators alike can venture into the emerging realm of cellular metabolism and immunity with confidence and rigour.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Murphy, M. P. & O’Neill, L. A. J. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell 174, 780–784 (2018).
Fan, J., Krautkramer, K. A., Feldman, J. L. & Denu, J. M. Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 10, 95–108 (2015).
Cameron, A. M., Lawless, S. J. & Pearce, E. J. Metabolism and acetylation in innate immune cell function and fate. Semin. Immunol. 28, 408–416 (2016).
Mason, E. F. & Rathmell, J. C. Cell metabolism: an essential link between cell growth and apoptosis. Biochem. Biophys. Acta 1813, 645–654 (2011).
Voss, K., Larsen, S. E. & Snow, A. L. Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response. Cancer Lett. 408, 190–196 (2017).
Green, D. R., Galluzzi, L. & Kroemer, G. Metabolic control of cell death. Science 345, 1457–1465 (2014).
Kim, B. et al. Discovery of widespread host protein interactions with the pre-replicated genome of CHIKV Using VIR-CLASP. Mol. Cell 78, 624–640 (2020).
Lv, Y., Tariq, M., Guo, X., Kanwal, S. & Esteban, M. A. Intricacies in the cross talk between metabolic enzymes, RNA, and protein translation. J. Mol. Cell Biol. 11, 813 (2019).
Tristan, C., Shahani, N., Sedlak, T. W. & Sawa, A. The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal. 23, 317–323 (2011).
Pollizzi, K. N. & Powell, J. D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14, 435–446 (2014).
Jellusova, J. Cross-talk between signal transduction and metabolism in B cells. Immunol. Lett. 201, 1–13 (2018).
Zasłona, Z. & O’Neill, L. A. J. Cytokine-like roles for metabolites in immunity. Mol. Cell 78, 814–823 (2020).
Baj, A. et al. Glutamatergic signaling along the microbiota-gut-brain axis. Int. J. Mol. Sci. 20, 1482 (2019).
Baumann, T. et al. Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal. Nat. Immunol. 21, 555–566 (2020).
Johnson, M. O., Siska, P. J., Contreras, D. C. & Rathmell, J. C. Nutrients and the microenvironment to feed a T cell army. Semin. Immunol. 28, 505–513 (2016).
Boothby, M. & Rickert, R. C. Metabolic regulation of the immune humoral response. Immunity 46, 743–755 (2017).
Gerriets, V. A. & Rathmell, J. C. Metabolic pathways in T cell fate and function. Trends Immunol. 33, 168–173 (2012).
Johnson, M. O. et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell 175, 1780–1795 (2018).
Jung, J., Zeng, H. & Horng, T. Metabolism as a guiding force for immunity. Nat. Cell Biol. 21, 85–93 (2019).
Zhang, J. & Zhang, Q. Using seahorse machine to measure OCR and ECAR in cancer cells. Methods Mol. Biol. 1928, 353–363 (2019).
van der Windt, G. J. W., Chang, C. H. & Pearce, E. L. Measuring bioenergetics in T cells using a seahorse extracellular flux analyzer. Curr. Prot. Immunol. 113, 16B.1–16B.14 (2016).
Pelgrom, L. R., van der Ham, A. J. & Everts, B. Analysis of TLR-induced metabolic changes in dendritic cells using the Seahorse XFe96 extracellular flux analyzer. Methods Mol. Biol. 1390, 273–285 (2016).
Mookerjee, S. A., Nicholls, D. G. & Brand, M. D. Determining maximum glycolytic capacity using extracellular flux measurements. PLoS ONE 11, e0152016 (2016).
Mookerjee, S. A. & Brand, M. D. Measurement and analysis of extracellular acid production to determine glycolytic rate. J. Vis. Exp. 106, 53464 (2015).
Raud, B. et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 28, 504–515.e7 (2018).
Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J. Biol. Chem. 292, 7189–7207 (2017). This is a helpful in-depth discussion of using extracellular flux assays and proper interpretation.
Newling, M. et al. C-reactive protein promotes inflammation through FcγR-induced glycolytic reprogramming of human macrophages. J. Immunol. 203, 225–235 (2019).
Saini, V. et al. Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis. Nat. Commun. 11, 557 (2020).
Franco da Cunha, F. et al. Extracellular vesicles isolated from mesenchymal stromal cells modulate CD4+ T lymphocytes toward a regulatory profile. Cells 9, 1059 (2020).
Curtis, K. D. et al. Glycogen metabolism supports early glycolytic reprogramming and activation in dendritic cells in response to both TLR and Syk-dependent CLR agonists. Cells 9, 715 (2020).
Mookerjee, S. A., Goncalves, R. L. S., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. The contributions of respiration and glycolysis to extracellular acid production. Biochim. Biophys. Acta 1847, 171–181 (2015).
Little, A. C. et al. High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Commun. Biol. 3, 271 (2020).
Sun, S., Li, H., Chen, J. & Qian, Q. Lactic acid: no longer an inert and end-product of glycolysis. Physiology 32, 453–463 (2017).
Menk, A. V. et al. Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions. Cell Rep. 22, 1509–1521 (2018).
Pelletier, M., Billingham, L. K., Ramaswamy, M. & Siegel, R. M. Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption. Methods Enzymol. 542, 125–149 (2014).
di Cara, F. et al. Peroxisomes in immune response and inflammation. Int. J. Mol. Sci. 20, 3877 (2019).
Nordgren, M. & Fransen, M. Peroxisomal metabolism and oxidative stress. Biochimie 98, 56–62 (2014).
Shi, L. & Tu, B. P. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr. Opin. Cell Biol. 33, 125–131 (2015).
Brooks, G. A. Cell-cell and intracellular lactate shuttles. J. Phys. 587, 5591–5600 (2009).
Wang, H. et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat. Immunol. 21, 298–308 (2020).
Ma, E. H. et al. Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8+ T cells. Immunity 51, 856–870.e5 (2019). This paper illustrates the power of 13C tracing to define metabolic pathways in vivo and shows that CD8+ T cells use glucose primarily for biosynthetic pathways rather than conversion into lactate.
Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282–1293.e7 (2017).
Binek, A. et al. Flow cytometry has a significant impact on the cellular metabolome. J. Prot. Res. 18, 169–181 (2019).
Llufrio, E. M., Wang, L., Naser, F. J. & Patti, G. J. Sorting cells alters their redox state and cellular metabolome. Redox Biol. 16, 381–387 (2018).
Xu, G. et al. Dissecting the human immune system with single cell RNA sequencing technology. J. Leukoc. Biol. 107, 613–623 (2020).
Chen, H., Ye, F. & Guo, G. Revolutionizing immunology with single-cell RNA sequencing. Cell. Mol. Immunol. 16, 242–249 (2019).
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
Hartmann, F. J. et al. Single-cell metabolic profiling of human cytotoxic T cells. Nat. Biotechnol. 39, 186–197 (2021). This paper demonstrates the potential of high-dimensional profiling of metabolic proteins in single cells to define metabolic phenotypes.
Subrahmanyam, P. B. & Maecker, H. T. CyTOF measurement of immunocompetence across major immune cell types. Curr. Protoc. Cytom. 82, 9.54.1–9.54.12 (2017).
Hartmann, F. J. & Bendall, S. C. Immune monitoring using mass cytometry and related high- dimensional imaging approaches. Nat. Rev. Rheum. 16, 87–99 (2020).
Artyomov, M. N. & van den Bossche, J. Immunometabolism in the single-cell era. Cell Metab. 32, 710–725 (2020).
Xue, M., Wei, W., Su, Y., Johnson, D. & Heath, J. R. Supramolecular probes for assessing glutamine uptake enable semi- quantitative metabolic models in single cells. J. Am. Chem. Soc. 138, 3085–3093 (2016).
Siska, P. J. et al. Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes. J. Immunol. Methods 438, 51–58 (2016).
Sinclair, L. V, Barthelemy, C. & Cantrell, D. A. Single cell glucose uptake assays: a cautionary tale. Immunometabolism 2, e200029 (2020). This paper highlights the contradictory results that can be obtained using fluorescent analogues of glucose to measure glucose uptake.
Evers, T. M. J. et al. Deciphering metabolic heterogeneity by single-cell analysis. Anal. Chem. 91, 13314–13323 (2019).
Zhang, L. & Vertes, A. Single-cell mass spectrometry approaches to explore cellular heterogeneity. Angew Chem. Int. Ed. 57, 4466–4477 (2018).
Galler, K. et al. Making a big thing of a small cell-recent advances in single cell analysis. Analyst 139, 1237–1273 (2014).
Siska, P. J. et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. JCI Insight 2, e93411 (2017).
Beckermann, K. E. et al. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation. JCI Insight 5, e138729 (2020).
Yucel, N. et al. Glucose metabolism drives histone acetylation landscape transitions that dictate muscle stem cell function. Cell Rep. 27, 3939–3955.e6 (2019).
Karmaus, P. W. F. et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature 565, 101–105 (2019). This study uses scRNA-seq to define in vivo metabolic phenotypes for pathogenic and stem TH17 cells.
Gaublomme, J. T. et al. Single-cell genomics unveils critical regulators of TH17 cell pathogenicity. Cell 163, 1400–1412 (2015).
Wang, C. et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163, 1413–1427 (2015).
Kimmey, S. C., Borges, L., Baskar, R. & Bendall, S. C. Parallel analysis of tri-molecular biosynthesis with cell identity and function in single cells. Nat. Commun. 10, 1185 (2019).
Ahl, P. J. et al. Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations. Commun. Biol. 3, 305 (2020).
Xiao, Z., Dai, Z. & Locasale, J. W. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat. Commun. 10, 1–12 (2019).
Jang, C., Chen, L. & Rabinowitz, J. D. Metabolomics and isotope tracing. Cell 173, 822–837 (2018).
Yuan, M. et al. Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC–MS/MS. Nat. Protoc. 14, 313–330 (2019).
Buescher, J. M. et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 34, 189–201 (2015).
Rinschen, M. M., Ivanisevic, J., Giera, M. & Siuzdak, G. Identification of bioactive metabolites using activity metabolomics. Nat. Rev. Mol. Cell Biol. 20, 353–367 (2019).
Patti, G. J., Yanes, O. & Siuzdak, G. Innovation: metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263–269 (2012).
Gu, H., Zhang, P., Zhu, J. & Raftery, D. Globally optimized targeted mass spectrometry: reliable metabolomics analysis with broad coverage. Anal. Chem. 87, 12355–12362 (2015).
Sindelar, M. & Patti, G. J. Chemical discovery in the era of metabolomics. J. Am. Chem. Soc. 142, 9097–9105 (2020).
Gallart-Ayala, H., Teav, T. & Ivanisevic, J. Metabolomics meets lipidomics: assessing the small molecule component of metabolism. BioEssays 42, 2000052 (2020).
Lu, W. et al. Metabolite measurement: pitfalls to avoid and practices to follow. Annu. Rev. Biochem. 86, 277–304 (2017). A helpful guide for navigating metabolomics of water-soluble metabolites, comparing the strengths and weaknesses of liquid chromatography–tandem mass spectrometry, gas chromatography–mass spectrometry and NMR.
Lee, H. J., Kremer, D. M., Sajjakulnukit, P., Zhang, L. & Lyssiotis, C. A. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics. Metabolomics 15, 103 (2019).
Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194–207 (2015).
Blagih, J. et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses invivo. Immunity 42, 41–54 (2015).
Geiger, R. et al. l-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829–842.e13 (2016).
Balmer, M. L. et al. Memory CD8+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity. 44, 1312–1324 (2016).
Balmer, M. L. et al. Memory CD8+ T cells balance pro- and anti-inflammatory activity by reprogramming cellular acetate handling at sites of infection. Cell Metab. 32, 457–467.e5 (2020). This study demonstrates that alternative fuels such as acetate can play key roles in T cell function in infection.
Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277–282 (2020).
Roy, D. G. et al. Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming. Cell Metab. 31, 250–266.e9 (2020).
Ron-Harel, N. et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 24, 104–117 (2016).
Ma, E. H. et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 25, 345–357 (2017).
Niedenführ, S., Wiechert, W. & Nöh, K. How to measure metabolic fluxes: a taxonomic guide for 13C fluxomics. Curr. Opin. Biotechnol. 34, 82–90 (2015).
Oruganty, K., Campit, S. E., Mamde, S., Lyssiotis, C. A. & Chandrasekaran, S. Common biochemical properties of metabolic genes recurrently dysregulated in tumors. Cancer Metab. 8, 5 (2020).
Llufrio, E. M., Cho, K. & Patti, G. J. Systems-level analysis of isotopic labeling in untargeted metabolomic data by X13CMS. Nat. Protoc. 14, 1970–1990 (2019).
Guijas, C., Montenegro-Burke, J. R., Warth, B., Spilker, M. E. & Siuzdak, G. Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat. Biotechnol. 36, 316–320 (2018).
Forsberg, E. M. et al. Data processing, multi-omic pathway mapping, and metabolite activity analysis using XCMS Online. Nat. Protoc. 13, 633–651 (2018).
Macintyre, A. N. et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61–72 (2014).
Voss, K., Luthers, C. R., Pohida, K. & Snow, A. L. Fatty acid synthase contributes to restimulation-induced cell death of human CD4 T cells. Front. Mol. Biosci. 6, 106 (2019).
Jia, Y. et al. Hyperactive PI3Kδ predisposes naive T cells to activation via aerobic glycolysis programs. Cell. Mol. Immunol. https://doi.org/10.1038/s41423-020-0379-x (2020).
Bibby, J. A. et al. Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate. Nat. Commun. 11, 3412 (2020).
Webster, D. E., Roulland, S. & Phelan, J. D. Protocols for CRISPR-Cas9 screening in lymphoma cell lines. Methods Mol. Biol. 1956, 337–350 (2019).
Sanjana, N. E. Genome-scale CRISPR pooled screens. Anal. Biochem. 532, 95–99 (2017).
LaFleur, M. W. et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat. Commun. 10, 1668 (2019).
Bailis, W. et al. Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function. Nature 571, 403–407 (2019). These two papers use in vivo pooled CRISPR gene targeting in forward genetic screens to identify key metabolic genes in haematopoietic cells and demonstrate crucial roles for mitochondrial metabolism.
Rossiter, N. J. et al. CRISPR screens in physiologic medium reveal conditionally essential genes in human cells. Cell Metab. https://doi.org/10.1016/j.cmet.2021.02.005 (2021).
Wroblewska, A. et al. Protein barcodes enable high-dimensional single-cell CRISPR screens. Cell 175, 1141–1155.e16 (2018).
Phan, A. T. et al. Constitutive glycolytic metabolism supports CD8+ T cell effector memory differentiation during viral infection. Immunity 45, 1024–1037 (2016).
Raud, B., McGuire, P. J., Jones, R. G., Sparwasser, T. & Berod, L. Fatty acid metabolism in CD8+ T cell memory: challenging current concepts. Immunol. Rev. 283, 213–231 (2018).
Gerriets, V. A. et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459–1466 (2016).
Waters, L. R., Ahsan, F. M., Wolf, D. M., Shirihai, O. & Teitell, M. A. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience 5, 99–109 (2018).
Franchi, L. et al. Inhibiting oxidative phosphorylation in vivo restrains Th17 effector responses and ameliorates murine colitis. J. Immunol. 198, 2735–2746 (2017).
Glick, G. D. et al. Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. J. Pharm. Exp. Ther. 351, 298–307 (2014).
Reinfeld, B. I. et al. Cell programmed nutrient partitioning in the tumor microenvironment. Nature https://doi.org/10.1038/s41586-021-03442-1 (2021).
Reid, M. A., Dai, Z. & Locasale, J. W. The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat. Cell Biol. 19, 1298–1306 (2017).
Tyrakis, P. A. et al. S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature 540, 236–241 (2016).
Xu, T. et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548, 228–233 (2017).
Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565, 495–499 (2019).
Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481–484 (2016).
Franco, F., Jaccard, A., Romero, P., Yu, Y. R. & Ho, P. C. Metabolic and epigenetic regulation of T-cell exhaustion. Nat. Metab. 2, 1001–1012 (2020).
Blank, C. U. et al. Defining ‘T cell exhaustion’. Nat. Rev. Immunol. 19, 665–674 (2019).
Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229–1241 (2015).
Lyssiotis, C. A. & Kimmelman, A. C. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 27, 863–875 (2017).
Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013–1021 (2019). This study demonstrates that glutamine restrains differentiation of TH1 and cytotoxic T cells, and a broad inhibitor of glutamine metabolism can enhance antitumour immunotherapy.
Bader, J. E., Voss, K. & Rathmell, J. C. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol. Cell 78, 1019–1033 (2020).
Halbrook, C. J. & Lyssiotis, C. A. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer. Cancer Cell 31, 5–19 (2017).
Wang, T. et al. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat. Metab. 2, 635–647 (2020).
Kurniawan, H. et al. Glutathione restricts serine metabolism to preserve regulatory T cell function. Cell Metab. 5, 920–936.e7 (2020).
Halbrook, C. J. et al. Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metab. 29, 1390–1399.e6 (2019).
Maj, T. et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat. Immunol. 18, 1332–1341 (2017).
Brunk, E. et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272–281 (2018).
Bordbar, A., Monk, J. M., King, Z. A. & Palsson, B. O. Constraint-based models predict metabolic and associated cellular functions. Nat. Rev. Genet. 15, 107–120 (2014).
Lagziel, S., Gottlieb, E. & Shlomi, T. Mind your media. Nat. Metab. 2, 1369–1372 (2020).
Ackermann, T. & Tardito, S. Cell culture medium formulation and its implications in cancer metabolism. Trends Cancer 5, 329–332 (2019).
Voorde, J. vande et al. Improving the metabolic fidelity of cancer models with a physiological cell culture medium. Sci. Adv. 5, eaau7314 (2019).
antor, J. R. et al. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 169, 258–272.e17 (2017). This study illustrates the value of physiological media for in vitro metabolic studies as an approach to more closely model in vivo metabolism.
Leney-Greene, M. A., Boddapati, A. K., Su, H. C., Cantor, J. R. & Lenardo, M. J. Human plasma-like medium improves T lymphocyte activation. iScience 23, 100759 (2020).
Ferrick, D. A., Neilson, A. & Beeson, C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Disc. Today 13, 268–274 (2008).
Xu, H. et al. Influence of various medium environment to in vitro human T cell culture. In Vitro Cell. Dev. Biol. Anim. 54, 559–566 (2018).
Sato, K. et al. Impact of culture medium on the expansion of T cells for immunotherapy. Cytotherapy 11, 936–946 (2009).
Medvec, A. R. et al. Improved expansion and in vivo function of patient T cells by a serum-free medium. Mol. Ther. Methods Clin. Dev. 8, 65–74 (2018).
Chan, G., Kleinheinz, T., Peterson, D. & Moffat, J. A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays. PLoS ONE 8, e63583 (2013).
Acknowledgements
The authors thank C. Deeter and K. V. Tormos at Agilent for helpful resources and discussion.
Funding
This work was supported by T32 DK101003 (K.V.), T32 DK094775 (H.S.H), K00 CA234920 (J.E.B.), T32 GM007347 (A.S.), 1R37CA237421, R01CA248160, R01CA244931 (C.A.L.) and R01 CA217987 and R01 DK105550 (J.C.R.).
Author information
Authors and Affiliations
Contributions
K.V. conceptualized the review and wrote the first draft. H.S.H. wrote the metabolomics section and contributed considerably to revisions. J.E.B. and A.S. contributed intellectually to the review, wrote some portions of the review and assisted with edits. C.A.L. and J.C.R. supervised and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
J.C.R. holds stock equity in Sitryx and within the past 2 years has received unrelated research support, travel and honoraria from Incyte, Sitryx, Caribou, Nirogy, Kadmon, Calithera, Tempest, Merck, Mitobridge and Pfizer. The other authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Immunology thanks N. Chandel and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- Microbiota–gut–brain axis
-
The network that enables bidirectional communication between gut bacteria and the brain.
- Electrochemical gradient
-
A gradient of electrochemical potential; in the case of the mitochondrion, to enable protons to move across the inner mitochondrial membrane.
- Anaplerotic pathway
-
Metabolic pathway, the activity of which replenishes pools of intermediates of the tricarboxylic acid cycle, which can also serve as precursors for other anabolic processes.
- Fragmentation state
-
The status of elongated or fused mitochondria versus smaller mitochondria as a result of fission.
- Metabolons
-
Non-covalent complexes of metabolic enzymes in a metabolic pathway, resulting in increased spatiotemporal efficiency.
- Metabolome
-
The complete set of metabolites present in a cell, biological fluid or tissue sample.
Rights and permissions
About this article
Cite this article
Voss, K., Hong, H.S., Bader, J.E. et al. A guide to interrogating immunometabolism. Nat Rev Immunol 21, 637–652 (2021). https://doi.org/10.1038/s41577-021-00529-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-021-00529-8
This article is cited by
-
Post-click labeling enables highly accurate single cell analyses of glucose uptake ex vivo and in vivo
Communications Biology (2024)
-
Cancer cell metabolism and antitumour immunity
Nature Reviews Immunology (2024)
-
The cancer-immune dialogue in the context of stress
Nature Reviews Immunology (2024)
-
Dynamic changes in the mouse hepatic lipidome following warm ischemia reperfusion injury
Scientific Reports (2024)
-
A call for accessible tools to unlock single-cell immunometabolism research
Nature Metabolism (2024)